Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evandro de Azambuja

Showing results (1-10 of 299) with videos related to

Pageof 30
Sort By:
The Oncologist|August 24, 2006
End-of-life care: the red alert for physiciansEvandro de Azambuja
ESMO Open|December 1, 2016
I-SPY 2: optimising cancer drug development in the 21st centuryRupert Bartsch, Evandro de Azambuja
Chinese Clinical Oncology|January 9, 2018
Choice of chemotherapy regimen for early HER2-positive breast cancer in elderly patientsNoam Pondé, Evandro de Azambuja
Nature Reviews. Clinical Oncology|July 26, 2019
PERSEPHONE - implications for clinical practice in 2019Noam Pondé, Evandro de Azambuja
Onkologie|September 26, 2012
Treatment options in anthracycline and/or taxane pretreated patients with metastatic breast cancerLina Pugliano, Evandro de Azambuja
ESMO Open|November 20, 2020
Atezolizumab in metastatic triple-negative breast cancer: IMpassion130 and 131 trials - how to explain different results?Maria Alice Franzoi, Evandro de Azambuja
Journal of the National Cancer Institute. Monographs|November 2, 2011
Neoadjuvant chemotherapy and targeted therapies: a promising strategyOtto Metzger-Filho, Evandro de Azambuja
Maturitas|October 22, 2011
Improving quality of life after breast cancer: dealing with symptomsAna Catarina Pinto, Evandro de Azambuja
ESMO Open|June 25, 2019
How I treat metastatic triple-negative breast cancerRafael Caparica, Matteo Lambertini, Evandro de Azambuja
ESMO Open|March 20, 2020
Lessons learned at SABCS 2019 and to-dos from immunotherapy in breast cancerDaniel Eiger, Mariana Brandão, Evandro de Azambuja
Pageof 30

Showing results (1-10 of 299) with videos related to

Sort By:
Pageof 30
The Oncologist|August 24, 2006
End-of-life care: the red alert for physiciansEvandro de Azambuja
ESMO Open|December 1, 2016
I-SPY 2: optimising cancer drug development in the 21st centuryRupert Bartsch, Evandro de Azambuja
Chinese Clinical Oncology|January 9, 2018
Choice of chemotherapy regimen for early HER2-positive breast cancer in elderly patientsNoam Pondé, Evandro de Azambuja
Nature Reviews. Clinical Oncology|July 26, 2019
PERSEPHONE - implications for clinical practice in 2019Noam Pondé, Evandro de Azambuja
Onkologie|September 26, 2012
Treatment options in anthracycline and/or taxane pretreated patients with metastatic breast cancerLina Pugliano, Evandro de Azambuja
ESMO Open|November 20, 2020
Atezolizumab in metastatic triple-negative breast cancer: IMpassion130 and 131 trials - how to explain different results?Maria Alice Franzoi, Evandro de Azambuja
Journal of the National Cancer Institute. Monographs|November 2, 2011
Neoadjuvant chemotherapy and targeted therapies: a promising strategyOtto Metzger-Filho, Evandro de Azambuja
Maturitas|October 22, 2011
Improving quality of life after breast cancer: dealing with symptomsAna Catarina Pinto, Evandro de Azambuja
ESMO Open|June 25, 2019
How I treat metastatic triple-negative breast cancerRafael Caparica, Matteo Lambertini, Evandro de Azambuja
ESMO Open|March 20, 2020
Lessons learned at SABCS 2019 and to-dos from immunotherapy in breast cancerDaniel Eiger, Mariana Brandão, Evandro de Azambuja
Pageof 30